Previous research has shown radiosensitization in response to dual PI3K/mTOR inhibitor treatment (in other cancer cell lines, both in vitro and in vivo) [32,33], but an in vitro condition does not adequately depict clinical scenarios. The gene discussed is MTOR; the disease is cancer.